Table 2.

Sensitivity analysis for the risk of HBV infection and HBsAg carriage.

Dose of hepatitis B vaccine	No. of subjects (no. of cases, prevalence)	HBV infection
		Unadjusted OR	P value	Adjusted OR	P value
5 μg	682 (12; 1.8%)	Reference		Reference
10 μg	850 (5; 0.6%)	0.33 (0.12–0.94)	0.038	0.33 (0.11–0.98)	.046
		HBsAg carriage
		Unadjusted OR	P value	Adjusted OR	P value
5 μg	682 (4; 0.6%)	Reference		Reference
10 μg	850 (2; 0.2%)	0.40 (0.07–2.19)	.29	0.31 (0.05–1.94)	.21
		Anti-HBc positive
		Unadjusted OR	P value	Adjusted OR	P value
5 μg	682 (12; 1.8%)	Reference		Reference
10 μg	850 (5; 0.6%)	0.33 (0.12–0.94)	.038	0.36 (0.12–1.07)	.067

Adjusted factors included resident (urban or rural), birth year (<2002, ≥2002), gender (male or female), birth place (hospital, home, or unknown), mother’s status of HBsAg (negative, positive, or unknown).